Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP578767.RAe_1Fh5S-k2bitOehaXPJmf6n1SRkNAnFRAfM9UTwS_A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP578767.RAe_1Fh5S-k2bitOehaXPJmf6n1SRkNAnFRAfM9UTwS_A130_assertion type Assertion NP578767.RAe_1Fh5S-k2bitOehaXPJmf6n1SRkNAnFRAfM9UTwS_A130_head.
- NP578767.RAe_1Fh5S-k2bitOehaXPJmf6n1SRkNAnFRAfM9UTwS_A130_assertion description "[There was an insignificant trend toward loss of BLU methylation with advancing clinical stages of SCC (84.8%, 67.7%, and 63.6% in stages I, II, and III/IV, respectively; P=0.08).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP578767.RAe_1Fh5S-k2bitOehaXPJmf6n1SRkNAnFRAfM9UTwS_A130_provenance.
- NP578767.RAe_1Fh5S-k2bitOehaXPJmf6n1SRkNAnFRAfM9UTwS_A130_assertion evidence source_evidence_literature NP578767.RAe_1Fh5S-k2bitOehaXPJmf6n1SRkNAnFRAfM9UTwS_A130_provenance.
- NP578767.RAe_1Fh5S-k2bitOehaXPJmf6n1SRkNAnFRAfM9UTwS_A130_assertion SIO_000772 17097722 NP578767.RAe_1Fh5S-k2bitOehaXPJmf6n1SRkNAnFRAfM9UTwS_A130_provenance.
- NP578767.RAe_1Fh5S-k2bitOehaXPJmf6n1SRkNAnFRAfM9UTwS_A130_assertion wasDerivedFrom befree-2016 NP578767.RAe_1Fh5S-k2bitOehaXPJmf6n1SRkNAnFRAfM9UTwS_A130_provenance.
- NP578767.RAe_1Fh5S-k2bitOehaXPJmf6n1SRkNAnFRAfM9UTwS_A130_assertion wasGeneratedBy ECO_0000203 NP578767.RAe_1Fh5S-k2bitOehaXPJmf6n1SRkNAnFRAfM9UTwS_A130_provenance.